Abstract
Phyllodes tumors (PTs) are rare neoplasms of the breast that are a challenge in clinical practice. Though mostly benign, they are notorious for local recurrence, requiring adjuvant treatments. This study was planned to report the clinicopathological features and outcomes of patients with PT treated at our center. Details of all patients who underwent surgery for PT in the last 6 years (December 2017–December 2023) were obtained from our prospectively maintained database. The demographic, clinical, radiological, pathological, and follow-up details were recorded and analyzed. Statistical analyses were carried out with Jamovi version 2.3.18. Out of 61 suspected PTs by triple assessment, 9 were excluded due to a non-phyllodes diagnosis on histopathology. We included 52 women with a mean age of 38.2 ± 11.0 years, most of whom were premenopausal (57.7%). BI-RADS 4 was the most common finding on radiological assessment (65.4%). Core needle biopsy (CNB) was the most frequently employed modality for histological diagnosis preoperatively (65.4% of cases). Wide local excisions (WLE) and mastectomies were done in 63.5% and 36.5% of patients, respectively. Benign, borderline, and malignant phyllodes constituted 67.3%, 15.4%, and 17.3% of tumors, respectively. Patients undergoing breast conservation surgery (BCS) had a significantly smaller mean tumor diameter than those who underwent a mastectomy (p < 0.001). Overall, the margin positivity rate was 34.6%. Patients undergoing mastectomy developed more local recurrence compared to WLE, although the difference was not significant (p = 0.400). The outcome following surgical excisions of large PTs in terms of margin positivity and local recurrence is the same, irrespective of whether BCS or mastectomy is done. A negative pathological margin width of > 1 mm appears acceptable. Malignant phyllodes with positive margins are associated with a higher rate of recurrence but positive margins in patients with other subtypes may not translate into recurrence, at least in the short term.
Similar content being viewed by others
References
Lissidini G, Mulè A, Santoro A et al (2022) Malignant phyllodes tumor of the breast: a systematic review. Pathologica 114(2):111–120. https://doi.org/10.32074/1591-951X-754
Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK (2006) Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 107(9):2127–2133. https://doi.org/10.1002/cncr.22228
Zhang Y, Kleer CG (2016) Phyllodes tumor of the breast: histopathologic features, differential diagnosis, and molecular/genetic updates. Arch Pathol Lab Med 140(7):665–671. https://doi.org/10.5858/arpa.2016-0042-RA
Fiks A (1981) Cystosarcoma phyllodes of the mammary gland—Müller’s tumor. For the 180th birthday of Johannes Müller. Virchows Arch A Pathol Anat Histol 392(1):1–6. https://doi.org/10.1007/BF00430543
Belkacémi Y, Bousquet G, Marsiglia H et al (2008) Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 70(2):492–500. https://doi.org/10.1016/j.ijrobp.2007.06.059
Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP (2001) Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol 27(8):723–730. https://doi.org/10.1053/ejso.2001.1207
Jang JH, Choi MY, Lee SK et al (2012) Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol 19(8):2612–2617. https://doi.org/10.1245/s10434-012-2307-5
Rosenberger LH, Thomas SM, Nimbkar SN et al (2021) Contemporary multi-institutional cohort of 550 cases of phyllodes tumors (2007–2017) demonstrates a need for more individualized margin guidelines. J Clin Oncol 39(3):178–189. https://doi.org/10.1200/JCO.20.02647
Akrami M, Tahmasebi S, Talei A, Abdollahi A, Hosseini S, Namazi M (2015) Clinical outcome of patients with breast phyllodes tumors: a retrospective analysis of 129 cases in Shiraz, Southern Iran. Middle East Journal of Cancer 6(4):267–273
Shankar M, Khambra P (2020) Phyllodes tumors of the breast treated in a tertiary health care center:case series. Int J Sci Res 9(3):41–41. https://doi.org/10.36106/ijsr
Sain B, Gupta A, Ghose A et al (2023) Clinico-pathological factors determining recurrence of phyllodes tumors of the breast: the 25-year experience at a tertiary cancer centre. J Pers Med 13(5):866. https://doi.org/10.3390/jpm13050866
Karim RZ, Gerega SK, Yang YH et al (2009) Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. Breast 18(3):165–170. https://doi.org/10.1016/j.breast.2009.03.001
Barrio AV, Clark BD, Goldberg JI et al (2007) Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 14(10):2961–2970. https://doi.org/10.1245/s10434-007-9439-z
Ramakant P, Chakravarthy S, Cherian JA, Abraham DT, Paul MJ (2013) Challenges in management of phyllodes tumors of the breast: a retrospective analysis of 150 patients. Indian J Cancer 50(4):345–348. https://doi.org/10.4103/0019-509X.123625
Sanjay S, Ketul P, Mohit S et al (2021) Study of clinicopathological factors and their impact on survival in phyllodes tumour of breast at tertiary care cancer centre in India. Cancer Treat Res Commun 29:100482. https://doi.org/10.1016/j.ctarc.2021.100482
Karim MO, Khan KA, Khan AJ, Javed A, Fazid S, Aslam MI (2020) Triple assessment of breast lump: should we perform core biopsy for every patient? Cureus 12(3):e7479. https://doi.org/10.7759/cureus.7479
Tan BY, Acs G, Apple SK et al (2016) Phyllodes tumours of the breast: a consensus review. Histopathology 68(1):5–21. https://doi.org/10.1111/his.12876
Lawton TJ, Acs G, Argani P et al (2014) Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors. Int J Surg Pathol 22:695–698. https://doi.org/10.1177/1066896914548763
Leibl S, Gogg-Kammerer M, Sommersacher A, Denk H, Moinfar F (2005) Metaplastic breast carcinomas: are they of myoepithelial differentiation? immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol 29(3):347–353. https://doi.org/10.1097/01.pas.0000152133.60278.d2
Moutte A, Chopin N, Faure C et al (2016) Surgical management of benign and borderline phyllodes tumors of the breast. Breast J 22(5):547–552. https://doi.org/10.1111/tbj.12623
Lu Y, Chen Y, Zhu L et al (2019) Local recurrence of benign, borderline, and malignant phyllodes tumors of the breast: a systematic review and meta-analysis. Ann Surg Oncol 26(5):1263–1275. https://doi.org/10.1245/s10434-018-07134-5
Ravindhran B, Rajan S (2020) Predictive factors of early recurrence in patients with phyllodes tumor of the breast. Eur J Breast Health 17(1):10–14. https://doi.org/10.5152/ejbh.2020.5712
de Roos WK, Kaye P, Dent DM (1999) Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast. Br J Surg 86(3):396–399. https://doi.org/10.1046/j.1365-2168.1999.01035.x
Chen WH, Cheng SP, Tzen CY et al (2005) Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol 91(3):185–194. https://doi.org/10.1002/jso.20334
Barth RJ Jr, Wells WA, Mitchell SE, Cole BF (2009) A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol 16(8):2288–2294. https://doi.org/10.1245/s10434-009-0489-2
Tan EY, Tan PH, Yong WS, et al (2006) Recurrent phyllodes tumours of the breast: pathological features and clinical implications [published correction appears in ANZ J Surg. 2006 Oct;76(10):956. Hoon, Tan Puay [corrected to Tan, Puay Hoon]; Hui, Ho G [corrected to Ho, Gay Hui]]. ANZ J Surg 76(6):476–480. https://doi.org/10.1111/j.1445-2197.2006.03754.x
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Anand, A., Jha, C.K., Sinha, U. et al. Phyllodes Tumors of the Breast—Experience in a Tertiary Care Center. Indian J Surg Oncol (2024). https://doi.org/10.1007/s13193-024-01926-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13193-024-01926-w